Welcome to the e-CCO Library!

What about the radiology?
Year: 2019
Source: 8th S-ECCO IBD Masterclass
Authors: Andrea Laghi
Created: Tuesday, 28 May 2019, 3:32 PM
Crohn's disease, MRI, CT scan, Ileo ceacal resection
Files: 1
What are risk factors for complicated IBD outcome?
Year: 2018
Source: 4th Basic ECCO: EduCational Course for Industry
Authors: Gecse Krisztina
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
What are the unmet needs and how can new type/innovative trials meet these?
Year: 2019
Source: 3rd School for Clinical Trialists
Authors: Gert van Assche
Created: Tuesday, 28 May 2019, 3:32 PM
Real world data, Outcome measures, Patient reported outcomes, Histological remission, Commercial, Investigator-led, Disease activity indices, Mucosal healing, Registries and Big data
Files: 1
What can we learn about the role of diet in IBD from across the globe?
Year: 2022
Source: 7th D-ECCO Workshop
Authors: Lihi Godny
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

Objectives:
1. To link between changes in IBD incidence rates and changes in lifestyle habits around the world
2. To demonstrate the global association between ultra-processed food intake and IBD risk
3. To review the literature focusing on the Mediterranean diet and IBD across the globe

What can we learn from rheumathology in terms of sequencing therapies (Tandem talk)
Year: 2022
Source: ECCO'22 Virtual
Authors: Daniel Aletaha; Maria Antonietta D'Agostino
Created: Tuesday, 24 May 2022, 8:13 PM
What causes IBD?
Year: 2020
Source: 5th Basic ECCO: EduCational COurse for Industry
Authors: Timothy Raine
Created: Tuesday, 23 June 2020, 4:58 PM
Last Modified: Monday, 31 May 2021, 5:27 PM by ECCO Administrator
Files: 1
What causes IBD?
Year: 2018
Source: 4th Basic ECCO: EduCational Course for Industry
Authors: Cleynen Isabelle
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
What clinicians expect from pathologists
Year: 2017
Source: 2nd H-ECCO IBD Masterclass
Authors: Lindsay J.
Histology
Files: 1
What did we achieve with the past IBD trials until now?
Year: 2019
Source: 3rd School for Clinical Trialists
Authors: Laurent Peyrin-Biroulet
Created: Tuesday, 28 May 2019, 3:32 PM
Real world data, Outcome measures, Patient reported outcomes, Histological remission, Commercial, Investigator-led, Disease activity indices, Mucosal healing, Registries and Big data
Files: 1
What do IBD nurses do?
Year: 2018
Source: 4th Basic ECCO: EduCational Course for Industry
Authors: Geens Patricia
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
What does the future hold for IBD clinical trials?
Year: 2017
Source: 2nd School for Clinical Trialists
Authors: Danese S.
Last Modified: Wednesday, 15 March 2017, 4:54 PM by Vesna Babaja
Files: 1
What dose and what route of mesalazine in UC? A network meta-analysis
Year: 2021
Source: JCC Podcast
Authors: Brigida Barberio
Created: Wednesday, 10 March 2021, 2:03 PM by Dauren Ramankulov

So many 5-ASA trials, so many guidelines - but what is the best dose and route we should be prescribing? According to Dr. Brigida Barberio and colleagues, network meta-analysis supports many aspects of current international guidelines, but highlights a key role for higher doses of oral 5-ASA for induction of remission in more extensive disease.

What environmental factors are modifiable? Lessons from non-IBD conditions
Year: 2022
Source: ECCO'22 Virtual
Authors: Benoit Nemery de Bellevaux
Created: Tuesday, 24 May 2022, 8:13 PM
What happens after a pouch operation?
Year: 2018
Source: 4th Basic ECCO: EduCational Course for Industry
Authors: Ding Nik
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
What histology can tell us: Are we speaking the same language? (Tandem Talk)
Year: 2021
Source: ECCO'21 Virtual
Authors: Roger M. Feakins; Fernando Magro
Created: Friday, 1 October 2021, 12:41 PM
Summary content

1. Should the target be histology?
2. Basic histology and definitions
3 Standardization - scoring
4. Histological remission and response
5. Usefulness of histology
6. Possible solutions and improvements

What is GRADE? An introduction to the methodology
Year: 2021
Source: 2nd Guideline Methodology and GRADE Workshop
Authors: Stefanos Bonovas
Created: Friday, 1 October 2021, 12:41 PM
Summary content

This talk aims to help developers of clinical practice guidelines learn how to use the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to frame health care questions, select and rate the importance of outcomes, grade the quality of evidence, create Summary of Findings Tables, and move from evidence to making recommendations.

What is IBD, and what is the difference between Ulcerative Colitis and Crohn’s Disease?
Year: 2018
Source: 4th Basic ECCO: EduCational Course for Industry
Authors: Mansfield John
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
What is IBD? Patient and physician perspective (Tandem talk)
Year: 2020
Source: 5th Basic ECCO: EduCational COurse for Industry
Authors: Evelyn Groß, Walter Reinisch
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
What is new in the IBD treatment?
Year: 2021
Source: 15th N-ECCO Network Meeting
Authors: Britta Siegmund
Created: Friday, 1 October 2021, 12:41 PM
Summary content

Educational Objectives:
1. To understand the way of dosing and administration of ustekinumab in UC
2. To understand dosing, efficacy, side-effects of Tofacitinib 
3. To be familiar with the sc administration of Vedolizumab
4. To be familiar with the sc Administration of infliximab

What is system biology?
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Dermot McGovern
Created: Tuesday, 28 May 2019, 3:32 PM
Outcome measures, Metabolomics, Epigenetics, Proteomics
Files: 1